MedPath

Comparison of Different HES Coload Volumes on the 90% ED of Norepinephrine

Not Applicable
Completed
Conditions
Adverse Effect
Interventions
Drug: Hydroxyethyl starch coload - 0 ml/kg
Drug: Hydroxyethyl starch coload - 5 ml/kg
Drug: Hydroxyethyl starch coload - 10 ml/kg
Registration Number
NCT05712018
Lead Sponsor
General Hospital of Ningxia Medical University
Brief Summary

The purpose of this study is to investigate the effect of different 6% hydroxyethyl starch (130/0.4) coload volumes on the 90% effective dose of norepinephrine infusion prophylaxis for hypotension during spinal anesthesia for cesarean section.

Detailed Description

Post-spinal anesthesia hypotension is a frequent complication during spinal anesthesia for cesarean section. The incidence of post-spinal anesthesia hypotension is as high as 62.1-89.7% if prophylactic measures are not taken. Coload has been highly demonstrated for prevention and/or treatment of post-spinal anesthesia hypotension. In addition, there's some evidence that prophylactic infusion of norepinephrine could effectively reduce the incidence of post-spinal anesthesia hypotension in parturients undergoing cesarean section. The purpose of this study is to investigate the effect of different 6% hydroxyethyl starch (130/0.4) coload volumes on the 90% effective dose of norepinephrine infusion prophylaxis for hypotension during spinal anesthesia for cesarean section.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
90
Inclusion Criteria
  • 18-45 years
  • Primipara or multipara
  • Singleton pregnancy ≥37 weeks
  • American Society of Anesthesiologists physical status classification I to II
  • Scheduled for cesarean section under spinal anesthesia
Exclusion Criteria
  • Body height < 150 cm
  • Body weight > 100 kg or body mass index (BMI) ≥ 40 kg/m2
  • Eclampsia or chronic hypertension or baseline blood pressure ≥180 mmHg
  • Hemoglobin < 7g/dl
  • Fetal distress, or known fetal developmental anomaly

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
0 ml/kg Hydroxyethyl starch coload groupHydroxyethyl starch coload - 0 ml/kgNo fluid coload was given. An initial infusion dose of prophylactic norepinephrine simultaneous with spinal anesthesia
5 ml/kg Hydroxyethyl starch coload groupHydroxyethyl starch coload - 5 ml/kg5 ml/kg 6% Hydroxyethyl starch (130/0.4) coload combined with an initial infusion dose of prophylactic norepinephrine simultaneous with spinal anesthesia.
10 ml/kg Hydroxyethyl starch coload groupHydroxyethyl starch coload - 10 ml/kg10 ml/kg 6% Hydroxyethyl starch (130/0.4) coload combined with an initial infusion dose of prophylactic norepinephrine simultaneous with spinal anesthesia.
Primary Outcome Measures
NameTimeMethod
ED 501-15 minutes after spinal anesthesia

The dose of prophylactic norepinephrine that would be effective in preventing postspinal anesthesia hypotension in 50% (effective dose, ED 50) of patients

ED 901-15 minutes after spinal anesthesia

The dose of prophylactic norepinephrine that would be effective in preventing postspinal anesthesia hypotension in 90% (ED90) of patients

Secondary Outcome Measures
NameTimeMethod
The incidence of post-spinal anesthesia hypotension1-15 minutes after spinal anesthesia

Systolic blood pressure (SBP) \< 80% of the baseline

The incidence of severe post-spinal anesthesia hypotension1-15 minutes after spinal anesthesia

Systolic blood pressure (SBP) \< 60% of the baseline

The incidence of bradycardia1-15 minutes after spinal anesthesia

Heart rate \< 60 beats/min

The incidence of nausea and vomiting1-15 minutes after spinal anesthesia

Presence of nausea and vomiting in patients after spinal anesthesia

The incidence of hypertension1-15 minutes after spinal anesthesia

Systolic blood pressure (SBP) \>120% of the baseline

pHImmediately after delivery

From umbilical arterial blood gases

Partial pressure of oxygen (PO2)Immediately after delivery

From umbilical arterial blood gases

Base excess (BE)Immediately after delivery

From umbilical arterial blood gases

APGAR score5 min after delivery

A= Appearance P=Pulse G=Grimace A=Attitude R=Respiration

Trial Locations

Locations (1)

General Hospital of Ningxia Medical University

🇨🇳

Yinchuan, Ningxia, China

General Hospital of Ningxia Medical University
🇨🇳Yinchuan, Ningxia, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.